Kynam Capital Management, LP Vertex Pharmaceuticals Inc Put Options Transaction History

Kynam Capital Management, LP

  • $1.22 Billion
  • Q3 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$460.0 - $505.78 $138 Million - $152 Million
-300,000 Reduced 90.91%
30,000 $14 Million
Q2 2024

Aug 14, 2024
BUY
$392.81 - $485.53 $90.3 Million - $112 Million
230,000 Added 230.0%
330,000 $155 Million
Q1 2024

May 15, 2024
BUY
$407.69 - $446.08 $40.8 Million - $44.6 Million
100,000 New
100,000 $41.8 Million

Others Institutions Holding VRTX

# of Institutions
1,724
Shares Held
221M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Kynam Capital Management, LP Portfolio

Follow Kynam Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kynam Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Kynam Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email